ATE234815T1 - Aminopyrrolidin-derivate, verfahren zur ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Aminopyrrolidin-derivate, verfahren zur ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE234815T1
ATE234815T1 AT00403106T AT00403106T ATE234815T1 AT E234815 T1 ATE234815 T1 AT E234815T1 AT 00403106 T AT00403106 T AT 00403106T AT 00403106 T AT00403106 T AT 00403106T AT E234815 T1 ATE234815 T1 AT E234815T1
Authority
AT
Austria
Prior art keywords
alkyl
aryl
production
pharmaceutical compositions
compositions containing
Prior art date
Application number
AT00403106T
Other languages
English (en)
Inventor
Pascal Bousquet
Jean-Daniel Ehrhardt
Veronique Bruban
Josiane Feldman
Stephan Schann
Elizabeth Scalbert
Bruno Pfeiffer
Pierre Renard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE234815T1 publication Critical patent/ATE234815T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00403106T 1999-11-17 2000-11-09 Aminopyrrolidin-derivate, verfahren zur ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen ATE234815T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914434A FR2801051B1 (fr) 1999-11-17 1999-11-17 Nouveaux composes aminopyrroline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE234815T1 true ATE234815T1 (de) 2003-04-15

Family

ID=9552203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00403106T ATE234815T1 (de) 1999-11-17 2000-11-09 Aminopyrrolidin-derivate, verfahren zur ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (22)

Country Link
US (1) US6300366B1 (de)
EP (1) EP1101756B1 (de)
JP (1) JP3274456B2 (de)
KR (1) KR100453981B1 (de)
CN (1) CN1158257C (de)
AT (1) ATE234815T1 (de)
AU (1) AU771745B2 (de)
BR (1) BR0005442A (de)
CA (1) CA2325781C (de)
DE (1) DE60001706T2 (de)
DK (1) DK1101756T3 (de)
EA (1) EA004042B1 (de)
ES (1) ES2194691T3 (de)
FR (1) FR2801051B1 (de)
HU (1) HUP0004543A3 (de)
MX (1) MXPA00011239A (de)
NO (1) NO317987B1 (de)
NZ (1) NZ508228A (de)
PL (1) PL343920A1 (de)
PT (1) PT1101756E (de)
SI (1) SI1101756T1 (de)
ZA (1) ZA200006731B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004000312A2 (de) 2002-06-19 2003-12-31 Solvay Pharmaceuticals Gmbh Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
GB201318886D0 (en) * 2013-10-25 2013-12-11 Givaudan Sa Improvements i or relating to organic compounds
CN114716359B (zh) * 2022-04-28 2023-01-17 广东医科大学 一种氢化吲哚亚胺非对映异构体的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2029297A1 (de) * 1970-06-13 1971-12-30 Farbenfabriken Bayer Ag, 5090 Leverkusen Neue Aminophenyl-cycloamidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US3887569A (en) * 1970-10-30 1975-06-03 Mcneilab Inc 2-Imino-piperidines
NL7412695A (nl) * 1974-09-26 1976-03-30 Stamicarbon De bereiding van een 2-amino-pyrrolinederivaat.
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
DE4425070A1 (de) * 1994-07-15 1996-01-18 Degussa Verfahren zur Herstellung optisch aktiver l-substituierter 2-(Aminomethyl)pyrrolidine

Also Published As

Publication number Publication date
FR2801051B1 (fr) 2001-12-14
EP1101756B1 (de) 2003-03-19
EA004042B1 (ru) 2003-12-25
PL343920A1 (en) 2001-05-21
EA200001077A3 (ru) 2001-08-27
CN1298872A (zh) 2001-06-13
AU771745B2 (en) 2004-04-01
HUP0004543A2 (hu) 2001-10-28
NZ508228A (en) 2001-03-30
AU7168000A (en) 2001-05-24
KR100453981B1 (ko) 2004-10-20
EA200001077A2 (ru) 2001-06-25
NO317987B1 (no) 2005-01-17
CA2325781C (fr) 2006-07-18
ZA200006731B (en) 2001-05-30
US6300366B1 (en) 2001-10-09
KR20010051776A (ko) 2001-06-25
NO20005797D0 (no) 2000-11-16
CA2325781A1 (fr) 2001-05-17
DE60001706D1 (de) 2003-04-24
MXPA00011239A (es) 2002-05-23
HK1036454A1 (en) 2002-01-04
BR0005442A (pt) 2001-07-03
JP3274456B2 (ja) 2002-04-15
DE60001706T2 (de) 2004-02-05
HUP0004543A3 (en) 2001-11-28
SI1101756T1 (en) 2003-06-30
ES2194691T3 (es) 2003-12-01
CN1158257C (zh) 2004-07-21
JP2001139545A (ja) 2001-05-22
NO20005797L (no) 2001-05-18
DK1101756T3 (da) 2003-07-14
PT1101756E (pt) 2003-06-30
HU0004543D0 (de) 2001-02-28
EP1101756A1 (de) 2001-05-23
FR2801051A1 (fr) 2001-05-18

Similar Documents

Publication Publication Date Title
BG107120A (bg) Нови бавнодействащи бетамиметици, метод за тяхното получаване и приложението им като лекарствени средства
TW200724136A (en) Pharmaceutical compositions comprising PPAR modulator
AR034268A1 (es) Compuestos derivados de piperidina, su uso en preparacion de medicamentos, composicion farmaceutica, metodo de tratamiento y proceso para su preparacion
ATE478885T1 (de) Pharmazeutische dopamin-glykokonjugat- zusammensetzungen und verfahren zu deren herstellung
ATE482968T1 (de) Estra-1,3,5(10)-trien-3-sulfamat derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
CY1107703T1 (el) Υποκατεστημενες δικετοπιπεραζινες και χρηση αυτων ως ανταγωνιστες οξυτοκινης
ATE337805T1 (de) Medizinische materialien und verfahren zu deren herstellung
DE602004010845D1 (de) Aroylfurane und aroylthiophene, die sich für die behandlung von krebs eignen
ATE482933T1 (de) Sulfopyrrolderivate
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
ATE234815T1 (de) Aminopyrrolidin-derivate, verfahren zur ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
HUP9700708A2 (hu) N-[(9-pirimido[1,2-a]indolil)-metil-fenil-acetil]-fenil-glicinol-származékok, az ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és intermedierjeik
ATE66913T1 (de) Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen.
ATE300542T1 (de) 1-glyoxlylamidindolizine zur behandlung von krebs
AR029468A1 (es) Derivados de aminoacidos n-mercaptoacilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ATE413407T1 (de) Pyrrolo(2,1-c)(1,4)benzodiazepin-dimere als antitumormittel und verfahren dafür
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
DE60041137D1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
ATE160566T1 (de) Amphotere tricyclische verbindungen als antihistaminische und antiallergische mittel
AR002715A1 (es) Derivados de piperazina y piperazinona heterociclos substituidos particularmente utiles como antagonistas de los receptores de taquikinina,composicion farmaceutica que incluye uno de dichos derivados, uso de dichos compuestos en la preparacion de las composiciones y procedimiento para la preparacion de los derivados
ZA200002151B (en) 1-AZA-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them.
AR034313A1 (es) Utilizacion de derivados de piridoindolona para la preparacion de medicamentos
ATE205212T1 (de) Substituierte 7,12-dioxabenzo(a)anthracenderivate,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1101756

Country of ref document: EP

REN Ceased due to non-payment of the annual fee